Clinical Trials List
Protocol NumberEMR 62202-504
Not yet recruiting
Phase II
-
Trial Applicant
MERCK LTD.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
150 participants
